Pharmacoepidemiological research of lipid-lowering therapy in ischemic heart disease

Abstract

The pharmacoepidemiological study includes a review of the use of lipid-lowering drugs with the main indicators of consumption - defined daily dose (DDD) and prescribed daily dose (PDD). Pharmacoepidemiological analysis revealed that the pharmacotherapy of ischemic heart disease in a sample of patients studied mainly prescribers Tulip (atorvastatin) at daily doses of 10 and 20 mg, as well Atoris (atorvastatin) in a daily dose of 10 mg. The total cost of lipid-lowering therapy in 660 patients with ischemic heart disease in 2009-2010 amounted to 440,1 thousand rubles. Applied consumption indicators showed that the maximum DDD - at tulip, PDD - at simgal and simvakard. The maximum value of DDD - at tulip, PDD - at zocor.

Keywords

• фармакоэпидемиологический анализ
• обзор применения лекарственных средств
• индикаторы назначения лекарственных средств
• установленная суточная доза
• назначенная суточная доза
• pharmacoepidemiological analysis
• drug utilization review
• indicators of drug prescribing
• defined daily dose
• prescribed daily dose